s6k1 Search Results


90
OriGene ka s6k
Figure 3 Overexpression of B55gamma in Glioma cells inhibits the phosphorylation of <t>S6K.</t> A. Overexpression of B55gamma in U251 decreases phosphorylation of S6K, but phosphorylation of 4EBP1 and mTOR and AKT have no significant change. B. U251 cells were transfected with control vector or B55gamma alone or B55gamma + S6K WT or B55gamma + S6K KA for 48 hrs. Cell viability assays were performed under the treatments of Rapamycin at 15 nM and 50 nM, DMSO treatment was control. C. Transfection of S6K WT and S6K KA into U251V and U251B55gamma cells followed by the measurements of cell viabilities under the glucose withdrawal for 24 hrs. Columns, mean of three independent experiments; bars, SE. **, P < 0.01; ***, P < 0.001.
Ka S6k, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/S6K1+(RPS6KB1)+(NM_001272043)+Human+Tagged+ORF+Clone/pm25792973-56-13-18
Average 90 stars, based on 1 article reviews
ka s6k - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

atp  (OriGene)
90
OriGene atp
Figure 3 Overexpression of B55gamma in Glioma cells inhibits the phosphorylation of <t>S6K.</t> A. Overexpression of B55gamma in U251 decreases phosphorylation of S6K, but phosphorylation of 4EBP1 and mTOR and AKT have no significant change. B. U251 cells were transfected with control vector or B55gamma alone or B55gamma + S6K WT or B55gamma + S6K KA for 48 hrs. Cell viability assays were performed under the treatments of Rapamycin at 15 nM and 50 nM, DMSO treatment was control. C. Transfection of S6K WT and S6K KA into U251V and U251B55gamma cells followed by the measurements of cell viabilities under the glucose withdrawal for 24 hrs. Columns, mean of three independent experiments; bars, SE. **, P < 0.01; ***, P < 0.001.
Atp, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/S6K1+(RPS6KB1)+(NM_003161)+Human+Recombinant+Protein/pmc08113471-278-25-35
Average 90 stars, based on 1 article reviews
atp - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

93
Addgene inc dominant negative s6k
Figure 3 Overexpression of B55gamma in Glioma cells inhibits the phosphorylation of <t>S6K.</t> A. Overexpression of B55gamma in U251 decreases phosphorylation of S6K, but phosphorylation of 4EBP1 and mTOR and AKT have no significant change. B. U251 cells were transfected with control vector or B55gamma alone or B55gamma + S6K WT or B55gamma + S6K KA for 48 hrs. Cell viability assays were performed under the treatments of Rapamycin at 15 nM and 50 nM, DMSO treatment was control. C. Transfection of S6K WT and S6K KA into U251V and U251B55gamma cells followed by the measurements of cell viabilities under the glucose withdrawal for 24 hrs. Columns, mean of three independent experiments; bars, SE. **, P < 0.01; ***, P < 0.001.
Dominant Negative S6k, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/pRK7-HA-S6K1-KR+(Plasmid+%238985)/pmc02519760-155-13-16
Average 93 stars, based on 1 article reviews
dominant negative s6k - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc prk7 ha s6k1 f5a e389 deltact
Figure 3 Overexpression of B55gamma in Glioma cells inhibits the phosphorylation of <t>S6K.</t> A. Overexpression of B55gamma in U251 decreases phosphorylation of S6K, but phosphorylation of 4EBP1 and mTOR and AKT have no significant change. B. U251 cells were transfected with control vector or B55gamma alone or B55gamma + S6K WT or B55gamma + S6K KA for 48 hrs. Cell viability assays were performed under the treatments of Rapamycin at 15 nM and 50 nM, DMSO treatment was control. C. Transfection of S6K WT and S6K KA into U251V and U251B55gamma cells followed by the measurements of cell viabilities under the glucose withdrawal for 24 hrs. Columns, mean of three independent experiments; bars, SE. **, P < 0.01; ***, P < 0.001.
Prk7 Ha S6k1 F5a E389 Deltact, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/pRK7-HA-S6K1-F5A-E389-deltaCT+(Plasmid+%238990)/pmc05942914-242-23-30
Average 93 stars, based on 1 article reviews
prk7 ha s6k1 f5a e389 deltact - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Addgene inc control injectionmarkers pcfj90
Figure 3 Overexpression of B55gamma in Glioma cells inhibits the phosphorylation of <t>S6K.</t> A. Overexpression of B55gamma in U251 decreases phosphorylation of S6K, but phosphorylation of 4EBP1 and mTOR and AKT have no significant change. B. U251 cells were transfected with control vector or B55gamma alone or B55gamma + S6K WT or B55gamma + S6K KA for 48 hrs. Cell viability assays were performed under the treatments of Rapamycin at 15 nM and 50 nM, DMSO treatment was control. C. Transfection of S6K WT and S6K KA into U251V and U251B55gamma cells followed by the measurements of cell viabilities under the glucose withdrawal for 24 hrs. Columns, mean of three independent experiments; bars, SE. **, P < 0.01; ***, P < 0.001.
Control Injectionmarkers Pcfj90, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/pRK7-HA-S6K1-WT+(Plasmid+%238984)/pm39946234-799-29-33
Average 93 stars, based on 1 article reviews
control injectionmarkers pcfj90 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

96
Proteintech p70s6 kinase
Effect of maternal DHA supplementation during lactation on the mTOR signaling pathway in weaning mice. (A) Representative Western blots of p-mTOR (S2448), total mTOR, <t>p-p70S6</t> kinase (T389), total p70S6 kinase, p-S6 ribosomal protein (S240/244) and total S6 ribosomal protein, and (B, C, D) the relative band intensities of phosphorylation levels normalized to their respective total proteins in jejunal tissue of mice from different groups. Data were expressed as the mean ± SEM; n = 4 per group. Significance was set at p < 0.05 ( * p < 0.05, ** p < 0.01). L-DHA: 150 mg/(kg body weight day) DHA; H-DHA: 450 mg/(kg body weight day) DHA. DHA, docosahexaenoic acid; mTOR, mammalian target of rapamycin.
P70s6 Kinase, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/p70(S6K)+Antibody/pmc11258037-151-51-55
Average 96 stars, based on 1 article reviews
p70s6 kinase - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

93
OriGene phospho p70s6k thr389
Effect of maternal DHA supplementation during lactation on the mTOR signaling pathway in weaning mice. (A) Representative Western blots of p-mTOR (S2448), total mTOR, <t>p-p70S6</t> kinase (T389), total p70S6 kinase, p-S6 ribosomal protein (S240/244) and total S6 ribosomal protein, and (B, C, D) the relative band intensities of phosphorylation levels normalized to their respective total proteins in jejunal tissue of mice from different groups. Data were expressed as the mean ± SEM; n = 4 per group. Significance was set at p < 0.05 ( * p < 0.05, ** p < 0.01). L-DHA: 150 mg/(kg body weight day) DHA; H-DHA: 450 mg/(kg body weight day) DHA. DHA, docosahexaenoic acid; mTOR, mammalian target of rapamycin.
Phospho P70s6k Thr389, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/S6K1+(RPS6KB1)+pThr389+Rabbit+Polyclonal+Antibody/pm30671946-86-30-42
Average 93 stars, based on 1 article reviews
phospho p70s6k thr389 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
OriGene human s6k1
Effect of maternal DHA supplementation during lactation on the mTOR signaling pathway in weaning mice. (A) Representative Western blots of p-mTOR (S2448), total mTOR, <t>p-p70S6</t> kinase (T389), total p70S6 kinase, p-S6 ribosomal protein (S240/244) and total S6 ribosomal protein, and (B, C, D) the relative band intensities of phosphorylation levels normalized to their respective total proteins in jejunal tissue of mice from different groups. Data were expressed as the mean ± SEM; n = 4 per group. Significance was set at p < 0.05 ( * p < 0.05, ** p < 0.01). L-DHA: 150 mg/(kg body weight day) DHA; H-DHA: 450 mg/(kg body weight day) DHA. DHA, docosahexaenoic acid; mTOR, mammalian target of rapamycin.
Human S6k1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/S6K1+(RPS6KB1)+(NM_001272042)+Human+Untagged+Clone/pmc05480610-18-21-25
Average 90 stars, based on 1 article reviews
human s6k1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

88
Addgene inc s6k1 pcdna3 plasmids
Antibodies, concentrations and manufacturers used
S6k1 Pcdna3 Plasmids, supplied by Addgene inc, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/pcDNA-Myc+S6K1+(Plasmid+%2326610)/pmc05960438-48-6-11
Average 88 stars, based on 1 article reviews
s6k1 pcdna3 plasmids - by Bioz Stars, 2026-10
88/100 stars
  Buy from Supplier

90
Addgene inc prk7 ha s6k1 f5a e389
Antibodies, concentrations and manufacturers used
Prk7 Ha S6k1 F5a E389, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/pRK7-HA-S6K1-F5A-E389+(Plasmid+%238988)/pmc05207268-466-18-25
Average 90 stars, based on 1 article reviews
prk7 ha s6k1 f5a e389 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

93
Addgene inc p70 s6k constructs
Antibodies, concentrations and manufacturers used
P70 S6k Constructs, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/pRK7-HA-S6K1-E389-D3E+(Plasmid+%238989)/pmc02993047-102-1-8
Average 93 stars, based on 1 article reviews
p70 s6k constructs - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

96
Carna Inc assay kit
Antibodies, concentrations and manufacturers used
Assay Kit, supplied by Carna Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s6k1/p70S6K/us08455477-1138-34-46
Average 96 stars, based on 1 article reviews
assay kit - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

Image Search Results


Figure 3 Overexpression of B55gamma in Glioma cells inhibits the phosphorylation of S6K. A. Overexpression of B55gamma in U251 decreases phosphorylation of S6K, but phosphorylation of 4EBP1 and mTOR and AKT have no significant change. B. U251 cells were transfected with control vector or B55gamma alone or B55gamma + S6K WT or B55gamma + S6K KA for 48 hrs. Cell viability assays were performed under the treatments of Rapamycin at 15 nM and 50 nM, DMSO treatment was control. C. Transfection of S6K WT and S6K KA into U251V and U251B55gamma cells followed by the measurements of cell viabilities under the glucose withdrawal for 24 hrs. Columns, mean of three independent experiments; bars, SE. **, P < 0.01; ***, P < 0.001.

Journal: Cancer cell international

Article Title: The association between Salt-inducible kinase 2 (SIK2) and gamma isoform of the regulatory subunit B55 of PP2A (B55gamma) contributes to the survival of glioma cells under glucose depletion through inhibiting the phosphorylation of S6K.

doi: 10.1186/s12935-015-0164-6

Figure Lengend Snippet: Figure 3 Overexpression of B55gamma in Glioma cells inhibits the phosphorylation of S6K. A. Overexpression of B55gamma in U251 decreases phosphorylation of S6K, but phosphorylation of 4EBP1 and mTOR and AKT have no significant change. B. U251 cells were transfected with control vector or B55gamma alone or B55gamma + S6K WT or B55gamma + S6K KA for 48 hrs. Cell viability assays were performed under the treatments of Rapamycin at 15 nM and 50 nM, DMSO treatment was control. C. Transfection of S6K WT and S6K KA into U251V and U251B55gamma cells followed by the measurements of cell viabilities under the glucose withdrawal for 24 hrs. Columns, mean of three independent experiments; bars, SE. **, P < 0.01; ***, P < 0.001.

Article Snippet: Vector containing GFPtagged ORF clone of Homo sapiens protein B55gamma, WT S6K or KA S6K were purchased from Origene.

Techniques: Over Expression, Phospho-proteomics, Transfection, Control, Plasmid Preparation

Figure 5 Knockdown of SIK in B55gamma overexpression cells recovers the phosphorylation of S6K. A. U251V, U251B55gamma, U138V and U138B55gamma cells were transfected with scramble siRNA (Ctr) or SIK2 siRNA. 48 hrs after siRNA transfection, cell lysates were prepared and Western blotting was performed to detect the phosphorylation of S6K statues. The β-actin protein was used as a loading control. B. U251B55gamma (left) and U138B55gamma (right) cells were transfected with scramble siRNA (Ctr) or SIK2 siRNA. 48 hrs after siRNA transfection, cell were plated into 6-well plate for overnight, then the regular medium was replaced by glucose free medium for 36 h-starvation followed by the cell viability assay. Columns, mean of three independent experiments; bars, SE. *, P < 0.05.

Journal: Cancer cell international

Article Title: The association between Salt-inducible kinase 2 (SIK2) and gamma isoform of the regulatory subunit B55 of PP2A (B55gamma) contributes to the survival of glioma cells under glucose depletion through inhibiting the phosphorylation of S6K.

doi: 10.1186/s12935-015-0164-6

Figure Lengend Snippet: Figure 5 Knockdown of SIK in B55gamma overexpression cells recovers the phosphorylation of S6K. A. U251V, U251B55gamma, U138V and U138B55gamma cells were transfected with scramble siRNA (Ctr) or SIK2 siRNA. 48 hrs after siRNA transfection, cell lysates were prepared and Western blotting was performed to detect the phosphorylation of S6K statues. The β-actin protein was used as a loading control. B. U251B55gamma (left) and U138B55gamma (right) cells were transfected with scramble siRNA (Ctr) or SIK2 siRNA. 48 hrs after siRNA transfection, cell were plated into 6-well plate for overnight, then the regular medium was replaced by glucose free medium for 36 h-starvation followed by the cell viability assay. Columns, mean of three independent experiments; bars, SE. *, P < 0.05.

Article Snippet: Vector containing GFPtagged ORF clone of Homo sapiens protein B55gamma, WT S6K or KA S6K were purchased from Origene.

Techniques: Knockdown, Over Expression, Phospho-proteomics, Transfection, Western Blot, Control, Viability Assay

Effect of maternal DHA supplementation during lactation on the mTOR signaling pathway in weaning mice. (A) Representative Western blots of p-mTOR (S2448), total mTOR, p-p70S6 kinase (T389), total p70S6 kinase, p-S6 ribosomal protein (S240/244) and total S6 ribosomal protein, and (B, C, D) the relative band intensities of phosphorylation levels normalized to their respective total proteins in jejunal tissue of mice from different groups. Data were expressed as the mean ± SEM; n = 4 per group. Significance was set at p < 0.05 ( * p < 0.05, ** p < 0.01). L-DHA: 150 mg/(kg body weight day) DHA; H-DHA: 450 mg/(kg body weight day) DHA. DHA, docosahexaenoic acid; mTOR, mammalian target of rapamycin.

Journal: Frontiers in Nutrition

Article Title: Maternal docosahexaenoic acid supplementation during lactation improves exercise performance, enhances intestinal glucose absorption and modulates gut microbiota in weaning offspring mice

doi: 10.3389/fnut.2024.1423576

Figure Lengend Snippet: Effect of maternal DHA supplementation during lactation on the mTOR signaling pathway in weaning mice. (A) Representative Western blots of p-mTOR (S2448), total mTOR, p-p70S6 kinase (T389), total p70S6 kinase, p-S6 ribosomal protein (S240/244) and total S6 ribosomal protein, and (B, C, D) the relative band intensities of phosphorylation levels normalized to their respective total proteins in jejunal tissue of mice from different groups. Data were expressed as the mean ± SEM; n = 4 per group. Significance was set at p < 0.05 ( * p < 0.05, ** p < 0.01). L-DHA: 150 mg/(kg body weight day) DHA; H-DHA: 450 mg/(kg body weight day) DHA. DHA, docosahexaenoic acid; mTOR, mammalian target of rapamycin.

Article Snippet: After transfer, the PVDF membrane was blocked for 1 h in 5% fat-free milk and then was, respectively, incubated overnight at 4°C with dilutions of primary antibodies: GLUT2 (A12307, 1:2000, Abclonal, China), SGLT1 (bs-1128R, 1:2000, Bioss, China), S6 ribosomal protein (abs131865, 1:2000, Absin, China), p-Ser240/244-S6 ribosomal protein (ab215214, 1:2000, Abcam, UK), p70S6 kinase (14485-1-AP, 1,1,000, Proteintech, China), p-Thr389-p70S6 kinase (9,234, 1,1,000, Cell Signaling Technology, United States), mammalian target of rapamycin (mTOR, T55306, 1:2000, Abmart, China), p-S2448-mTOR (5,536, 1,1,000, Cell Signaling Technology), β-actin (T40104, 1:4000, Abmart).

Techniques: Western Blot, Phospho-proteomics

Antibodies, concentrations and manufacturers used

Journal: Neuroscience letters

Article Title: The mTOR cell signaling pathway is crucial to the long-term protective effects of ischemic postconditioning against stroke

doi: 10.1016/j.neulet.2018.03.062

Figure Lengend Snippet: Antibodies, concentrations and manufacturers used

Article Snippet: The S6K1 gene was cloned from S6K1 (pcDNA3) plasmids (S6K1: 26610, Addgene, Cambridge, MA) and inserted into the lentiviral backbone plasmid, pHR’trIPostCMV-IRES-eGFP.

Techniques: